Josephson-Wallack-Munshower Neurology (JWM) is a group of highly specialized physicians who understand the anxiety, fear, and hopelessness you may be feeling when faced with a neurological disorder. Whether you're challenged with unexplainable headaches, disorders such as epilepsy or Parkinson's disease, or an inability to sleep, we will provide you with expertise and comprehensive care in a compassionate environment. We're one of the state's largest neurology physician groups.
If you suffer from certain diseases and conditions, seeing a neurologist can help you. A neurologist is a physician who specializes in the diagnosis and treatment of disorders of the central nervous system. The central nervous system consists of the brain, spinal cord, and all the nerves in your body.
In addition to four years of premedical education and four years of medical school, neurologists complete at least three years of specialized training in an accredited neurology residency program.
Some of the diseases and conditions treated by a neurologist are Alzheimer's disease, Parkinson's disease, multiple sclerosis (MS), various forms of dementia, sleep disorders, headaches, brain tumors, strokes, seizures, myasthenia gravis, and chronic pain.
Many diseases and conditions treated by a neurologist are treated with medication and/or certain therapies. If your condition necessitates surgery, we will refer you to an appropriate surgeon.
To learn more about JWM Neurology, the type of care we provide, and our physicians, click on the "JWM Specialties" and "Our Physicians" buttons on the left-hand side of this page. If you have questions, feel free to contact us at 317.308.2800.
Multiple Sclerosis Educational Talk For Patients & Families
Join Craig E. Herrman, MD, Director of JWM Neurology Research, as he presents a brief talk on the basics of Multiple Sclerosis. This is geared toward patients and families.
JWM Neurology Welcomes Matthew G. Gentry, MD
Neurologist Matthew G. Gentry, MD, has joined JWM Neurology. Dr. Gentry received his Medical Degree in 2011 at Indiana University School of Medicine in Indianapolis. He completed his Neurology Residency in 2015, also at IU School of Medicine, where he was Chief Resident. Dr. Gentry recently completed his Fellowship in Clinical Neurophysiology with an emphasis in EEG and Epilepsy at IU School of Medicine. He sees patients with all neurologic conditions and has special interests in the areas of Epilepsy, EEG, neuromuscular conditions and EMG.
Dr. David Glander Featured on Dick Wolfsie
JWM Neurologist, Dr. David Glander, was recently featured on the Dick Wolfsie Show on WISH TV 8. Watch the 4 video interview demonstrations of exciting TeleStroke technology that is being utilized.
JWM Neurology Welcomes Kevin J. Puzio, MD
The physicians at JWM Neurology welcome neurologist, Kevin J. Puzio, MD. Dr. Puzio sees adult patients in our Indianapolis offices with all types of neurologic disorders.
Central Indiana Neurology Joins JWM Neurology
Central Indiana Neurology (CIN) located in Anderson, Indiana has joined JWM Neurology.
Our collaborative partnership together will enable us to combine and serve a larger geographic area in Central Indiana as well as continue to better serve our patients and referring physicians. Between JWM and CIN, we now have eleven locations including offices in: Indianapolis, Carmel, Mooresville, Franklin, Kokomo, Anderson and Elwood.
JWM welcomes Central Indiana Neurology physicians, Larry Blankenship, MD, Charles Howe, MD, Christopher Rocco, MD, Caroline Stevens, DO and their staff.
Now Available In Indianapolis: PET-CT Tracer to Help Diagnose Alzheimer’s Disease and Memory Disturbances
Northwest Radiology and JWM Neurology, both located in Indianapolis, are partnering together to offer the first and only FDA-approved diagnostic PET-CT (Positive Emission Tomography-Computed Tomography) tracer for imaging beta-amyloid neuritic plaques in the living brain. For the first time in clinical practice, physicians are now able to utilize PET-CT scanning to see evidence of amyloid plaques (deposits in the gray matter associated with brain degeneration) when evaluating patients for Alzheimer’s disease and other causes of cognitive decline. Currently, only a neuropathological exam (performed during an autopsy) can definitively diagnose Alzheimer’s disease.